BioVie Inc.
BIVI · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $229 | $0 | $0 | $0 |
| Gross Profit | -$229 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $9,267 | $23,100 | $33,300 | $17,258 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $8,570 | $0 | $11,552 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $9,079 | $229 | $9,995 |
| Operating Expenses | $17,837 | $32,180 | $45,080 | $27,253 |
| Operating Income | -$18,066 | -$32,180 | -$45,080 | -$27,253 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $524 | $59 | -$5,175 | $1,169 |
| Pre-Tax Income | -$17,542 | -$32,121 | -$50,256 | -$26,084 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$17,542 | -$32,121 | -$50,256 | -$26,084 |
| % Margin | – | – | – | – |
| EPS | -12.12 | -73.05 | -154.7 | -106 |
| % Growth | 83.4% | 52.8% | -45.9% | – |
| EPS Diluted | -12.12 | -73.05 | -154.7 | -106 |
| Weighted Avg Shares Out | 1,477 | 452 | 325 | 247 |
| Weighted Avg Shares Out Dil | 1,477 | 452 | 325 | 247 |
| Supplemental Information | – | – | – | – |
| Interest Income | $853 | $1,137 | $562 | $44 |
| Interest Expense | $333 | $2,894 | $4,300 | $2,163 |
| Depreciation & Amortization | $229 | $229 | $229 | $229 |
| EBITDA | -$16,980 | -$31,950 | -$45,726 | -$27,024 |
| % Margin | – | – | – | – |